|
⚲
|
| Keyboard |
| Kalin Katherine Bach
✚
|
|
|---|---|
| CIK # | 0001832671 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001832671] | |
| 4 | [0001832671] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SELLAS Life Sciences Group Inc | |
| Kalin Katherine Bach | |
| Athersys Inc / New |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2026-01-07 | Grant | 50,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-11-19 | Buy | 63,400 | $1.59 | 100,806 |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-05-22 | Buy | 20,000 | $1.80 | 36,000 |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2025-01-10 | Grant | 12,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2025-01-10 | Grant | 18,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2024-01-22 | Grant | 6,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2024-01-22 | Grant | 10,000 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2023-02-02 | Grant | 9,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2023-02-02 | Grant | 2,500 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Stock Option (Right to Buy) · derivative
|
2022-08-13 | Grant | 19,000 | $0.00 | |
|
Athersys Inc / New ATHX
NonQualified Stock Option (right to purchase) · derivative
|
2021-06-15 | Grant | 50,000 | $0.00 | |
|
Athersys Inc / New ATHX
NonQualified Stock Option (right to purchase) · derivative
|
2020-11-12 | Grant | 100,000 | $0.00 |